Background and aims People who inject drugs (PWID) are a key population at high risk of
hepatitis C virus (HCV) infection. The aim of this study was to delineate the epidemiology of …

Hepatitis C is a global public health threat. The introduction of direct-acting antivirals (DAAs)
brings the prospect of curing the 71 million people living with the disease, dramatically …

Background With one in every 20 Pakistanis already infected, Pakistan has the second
largest number of hepatitis C virus (HCV) infections globally. The aim of this study was to …

Background Direct-acting antivirals opened an opportunity for eliminating hepatitis C virus
(HCV) infection in the Middle East and North Africa (MENA), the region most affected by …

This study characterized population-level trends and associations with hepatitis C virus
(HCV) antibody (Ab) prevalence in the Middle East and North Africa (MENA). Data source …

BACKGROUND The presence of hepatitis C virus (HCV) RNA in liver tissue or peripheral
blood mononuclear cells with no identified virus genome in the serum has been reported …

To decrease bowel cancer incidence and improve survival, we need to understand the
mechanisms that drive tumorigenesis. Recently, B-cell lymphoma 3 (BCL-3; a key regulator …

Infection with the hepatitis C virus (HCV) remains a considerable public health concern in
the Middle East and North Africa (MENA). The objectives of this study were to analyze the …

Summary Background The Middle East and North Africa (MENA) region is the most affected
by hepatitis C virus (HCV) infection globally. This study aimed to estimate HCV incidence …

Objective Direct-acting antivirals have opened an opportunity for controlling hepatitis C virus
(HCV) infection in Pakistan, where 10% of the global infection burden is found. We aimed to …